(Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | (Q3)Oct 31, 2022 | (Q2)Jul 31, 2022 | (Q1)Apr 30, 2022 | (FY)Jan 31, 2022 | (Q4)Jan 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 107.53%16.93K | -96.87%-668.65K | 58.78%-1.53M | -84.86%-5.94M | -131.12%-1.68M | 77.13%-224.79K | 61.35%-339.64K | -490.34%-3.7M | -64.11%-3.21M | 50.15%-726.04K |
Net income from continuing operations | -13.42%-2.04M | -21.74%-1.93M | -41.94%-2.11M | 43.37%-7.43M | 50.59%-2.56M | 70.25%-1.8M | -55.09%-1.59M | -69.35%-1.48M | -580.84%-13.13M | -412.83%-5.19M |
Operating gains losses | -420.02%-427.54K | 152.39%34.05K | -170.37%-116.65K | -347.75%-248.38K | -32.30%-58.02K | -995.62%-82.22K | -6,618.56%-64.99K | -744.84%-43.15K | -146.33%-55.47K | -224.37%-43.86K |
Depreciation and amortization | 7.23%6.99K | 12.23%7.6K | 5.81%6.85K | 0.42%24.63K | -37.23%4.87K | -2.62%6.52K | 27.94%6.77K | 35.22%6.48K | 114.27%24.53K | 150.86%7.75K |
Asset impairment expenditure | ---- | ---- | ---- | --16.72K | ---- | ---- | ---- | ---- | --0 | ---- |
Remuneration paid in stock | 453.26%34.96K | -76.00%41.42K | 170.11%49.63K | -85.99%558.25K | -64.31%466.36K | -100.38%-9.9K | 231.41%172.56K | -271.47%-70.78K | 5,175.03%3.98M | 2,878.52%1.31M |
Other non cashItems | 3,179.97%1.7M | 2,820.78%1.27M | 235,994.53%1.51M | 7,374.24%940.78K | 645.46%844.92K | -38.61%51.76K | 0.49%43.46K | -98.40%640 | -83.57%12.59K | -1,551.33%-154.9K |
Change In working capital | -53.80%741.29K | -107.90%-86.31K | 58.80%-868.82K | -96.65%199.45K | -111.57%-388.58K | -32.39%1.6M | 2,352.81%1.09M | -1,347.70%-2.11M | 3,517.94%5.95M | 784.17%3.36M |
-Change in receivables | 108.48%14.72K | -1,110.76%-122.82K | -97.32%561 | 135.37%52.46K | 317.72%192.88K | -176.80%-173.52K | 115.92%12.15K | 137.78%20.96K | -655.91%-148.31K | 196.29%46.17K |
-Change in prepaid assets | 111.43%15.51K | -106.17%-5.53K | 98.14%-1.58K | -98.62%3.61K | -10.18%134.92K | -2,430.93%-135.76K | -10.14%89.58K | -627.26%-85.14K | 216.82%260.69K | 158.06%150.22K |
-Change in payables and accrued expense | -61.76%729.46K | -104.42%-43.06K | 57.64%-865.95K | -98.99%58.77K | -124.61%-778.34K | -21.86%1.91M | 4,504.41%973.65K | -1,081.34%-2.04M | 8,380.34%5.83M | 1,815.92%3.16M |
-Change in other current liabilities | ---- | ---- | ---- | --43.87K | ---- | ---- | ---- | ---- | --0 | ---- |
-Change in other working capital | -402.42%-18.4K | --85.09K | ---1.84K | --40.74K | --18.1K | --6.08K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 107.53%16.94K | -96.87%-668.65K | 58.78%-1.53M | -84.86%-5.94M | -131.12%-1.68M | 77.13%-224.79K | 61.35%-339.64K | -490.34%-3.7M | -64.11%-3.21M | 50.15%-726.04K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -52.61%-18.62K | 76.23%-5.14K | 88.43%-4.63K | 30.32%-69.69K | -97.68%4.15K | 87.84%-12.2K | 71.47%-21.64K | 60.96%-40K | -99.70%-100.01K | 544.54%178.57K |
Net PPE purchase and sale | --0 | 122.56%1.11K | 94.34%-1.11K | 61.54%-23.48K | 99.36%-166 | 106.40%1.18K | 13.53%-4.92K | -80.82%-19.58K | -230.40%-61.05K | -204.37%-26.08K |
Net intangibles purchas and sale | -39.13%-18.62K | 62.61%-6.25K | 82.77%-3.52K | -18.60%-46.2K | -97.89%4.31K | 83.65%-13.38K | 76.16%-16.72K | 77.72%-20.41K | -23.27%-38.96K | --204.65K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -52.61%-18.62K | 76.23%-5.14K | 88.43%-4.63K | 30.32%-69.69K | -97.68%4.15K | 87.84%-12.2K | 71.47%-21.64K | 60.96%-40K | -99.70%-100.01K | 544.54%178.57K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -100.27%-11.61K | -107.48%-11.29K | 0 | 106.44%6.88M | -111.35%-205.91K | 541.57%4.3M | -3.05%150.94K | 280.27%2.64M | 19.40%3.33M | -30.19%1.81M |
Net issuance payments of debt | -570.34%-11.61K | -107.48%-11.29K | --0 | --0 | -140.41%-142.12K | -99.30%2.47K | 13,979.85%150.94K | -101.99%-11.28K | --1.27M | --351.67K |
Net common stock issuance | --0 | --0 | --0 | 106.78%2.63M | -101.06%-13.44K | --0 | --0 | --2.65M | -49.83%1.27M | --1.27M |
Net preferred stock issuance | ---- | ---- | ---- | --4.25M | ---50.35K | ---- | ---- | ---- | --0 | --0 |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 210.72%784.03K | 216.47%188.3K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -100.27%-11.61K | -107.48%-11.29K | --0 | 106.44%6.88M | -111.35%-205.91K | 541.57%4.3M | -3.05%150.94K | 280.27%2.64M | 19.40%3.33M | -30.19%1.81M |
Net cash flow | ||||||||||
Beginning cash position | -51.01%30K | 166.63%720.37K | 62.97%2.24M | 1.26%1.38M | 3,654.31%4.12M | -88.34%61.23K | -79.48%270.17K | 1.26%1.38M | 135.18%1.36M | -56.73%109.8K |
Current changes in cash | -100.33%-13.29K | -225.70%-685.08K | -38.52%-1.53M | 4,786.92%867.23K | -248.48%-1.88M | 1,082.60%4.06M | 73.67%-210.34K | -2,957.09%-1.1M | -97.73%17.75K | 14.97%1.27M |
Effect of exchange rate changes | 81.21%-133 | -478.53%-5.29K | 341.72%6.03K | 74.19%-144 | 38.33%1.66K | 65.66%-708 | -81.33%1.4K | 65.26%-2.49K | -77.71%-558 | -75.39%1.2K |
End cash Position | -99.60%16.57K | -51.01%30K | 166.63%720.37K | 62.97%2.24M | 62.97%2.24M | 3,654.31%4.12M | -88.34%61.23K | -79.48%270.17K | 1.26%1.38M | 1.26%1.38M |
Free cash from | 99.29%-1.69K | -86.50%-673.79K | 59.10%-1.53M | -81.38%-6.01M | -205.74%-1.67M | 78.13%-236.99K | 62.15%-361.28K | -412.88%-3.74M | -65.00%-3.31M | 63.42%-547.47K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data